CTOs on the Move

Connect Hearing

www.connecthearing.com

 
We provide a strong network of convenient neighborhood hearing care centers across the country that continually strives to find innovative ways to serve you better. Our Hearing Care Professionals are passionate about helping people to hear better, applying a consistent process to determine the best recommendations for your hearing health. We provide free next day evaluations with professional recommendations based upon your inidiviudal hearing needs and lifestyle. We offer a walk-in, walk-out 2-week FREE trial with hearing aids that are right for you - plus the Connect Advantage, your assurance Connect Hearing will be there every step of the way. Headquartered in the Chicago ...
  • Number of Employees: 0-25
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Sven Davies
 Vice President of Information Technology Profile

Similar Companies

CSI Medical Education

CSI Medical Education is a Madison, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hand Surgery Associates

Hand Surgery Associates is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Denver, CO. To find more information about Hand Surgery Associates, please visit www.hsacolorado.com

Amrus Enterprises

Amrus Enterprises is a Fords, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Agili-T Health Solutions

Agili-T Health Solutions is a Varennes, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Envisia Therapeutics

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.